Also, it has been reported that miR-218 reduced self-renewal capacity in glioma stem-like cells by targeting stem cell promoting oncogene BMI1(BMI1 proto-oncogene, polycomb ring finger)29. The gene discussed is BMI1; the disease is central nervous system cancer.